U.S. hospitals testing experimental therapies to prevent two common bacterial infections
Antibacterial Resistance Leadership Group with a large international consortium leading the effort, the U.S. investigators hope to enroll 30 adult patients from 15 intensive care units in the trials. NIAID is supporting the domestic sites with a grant to Duke University. February 23, 2018